Eli Lilly data scientist resume tips and portfolio 2026

TL;DR

Tailor your resume to Eli Lilly’s therapeutic‑area focus and quantify impact with specific metrics from real projects. Show a portfolio that links code, visualizations, and business outcomes, not just a list of tools. In debriefs, hiring managers reject candidates whose resumes read like generic job ads rather than evidence of judgment in data‑driven product decisions.

Who This Is For

This guide is for mid‑level data scientists (2‑5 years of experience) targeting Eli Lilly’s Research & Development, Commercial Analytics, or Real‑World Evidence teams. It assumes you have worked with Python/R, SQL, and basic statistical modeling, and that you are preparing a resume and portfolio for a 2026 campus or experienced hire cycle. If you are a recent graduate or a senior scientist seeking a leadership track, adjust the emphasis accordingly but keep the judgment‑first framing.

What should I put in the summary section of my Eli Lilly data scientist resume?

The summary must state the therapeutic area you have impacted and the decision you enabled, not just your title or years of experience. In a Q3 debrief for a Diabetes Analytics role, the hiring manager pushed back on a candidate who wrote “Experienced data scientist with expertise in machine learning” because it gave no signal of judgment about which problem to solve.

The winning candidate opened with “Built a real‑world evidence pipeline that reduced cycle time for insulin‑dose adjustment studies by 30 %, enabling faster go‑to‑market for a new basal analog.” That sentence tells the reviewer what you did, why it mattered to Lilly, and what metric you moved. Keep it to two lines; any longer dilutes the judgment signal.

How do I demonstrate impact without revealing confidential Lilly data?

Use sanitized, aggregated metrics that preserve the business narrative while removing patient‑level identifiers. In a recent HC discussion, a senior scientist rejected a portfolio piece that displayed raw HbA1c distributions from a Lilly trial, noting it violated data‑use agreements and showed poor judgment about confidentiality.

The same candidate later resubmitted a version showing “average HbA1c reduction of 0.6 % across 12 k de‑identified patients, with a 95 % confidence interval of 0.4‑0.8 %,” and the team approved it because the insight remained clear and the risk was eliminated. Always ask yourself: does this number reveal a pattern that could be reverse‑engineered to a specific study? If yes, aggregate further or switch to a process metric like model‑update latency or feature‑creation speed.

Which technical skills should I highlight, and how deep should I go?

Highlight the stack that maps to Lilly’s current tooling: Python (pandas, scikit‑learn, statsmodels), R (tidyverse, survival analysis), SQL, and experience with cloud‑based notebooks (Azure Databricks or AWS SageMaker). Depth matters only when you can tie it to a decision.

In a debrief for a Real‑World Evidence role, a candidate listed “expert in deep learning” but could not explain why a simpler logistic regression was chosen for a market‑access model; the hiring manager judged that as signal‑noise confusion. Conversely, another candidate noted “implemented a gradient‑boosted model to predict adherence, achieving AUC 0.82, then switched to a penalized logistic regression after stakeholder feedback showed need for interpretable odds ratios.” That depth demonstrated judgment about model choice, not just tool proficiency. List only those skills you have applied to a Lilly‑relevant problem and be ready to discuss the trade‑offs you made.

How should I structure my portfolio to impress Eli Lilly reviewers?

Structure each portfolio piece as a mini‑case study: problem statement, data approach, model choice, validation, business impact, and next steps. A hiring manager in the Oncology Analytics team told me that the best portfolio she saw in 2024 had three pieces, each under two pages, with a clear “decision enabled” header. One piece described building a survival‑analysis model to estimate progression‑free survival for a new immuno‑oncology combo; the impact was a 15 % reduction in required sample size for a Phase II trial, saving roughly $2 M.

Another piece showed a dashboard that tracked real‑world drug‑utilization patterns, leading to a revision of the sales‑force call‑frequency plan. The third piece was a data‑pipeline automation that cut ETL time from 6 hours to 45 minutes, freeing analysts for exploratory work. Each piece included a link to a GitHub repo with a README that explained how to reproduce the analysis using synthetic data. Avoid dumping notebooks without context; reviewers judge your ability to communicate insight, not just to run code.

Preparation Checklist

Map your past projects to Lilly’s current therapeutic‑area priorities (oncology, diabetes, immunology, neuroscience) and write a one‑sentence impact statement for each.
Quantify every outcome with a metric that matters to Lilly (cycle‑time reduction, cost avoidance, sample‑size savings, prediction accuracy, or decision latency).
Remove or aggregate any patient‑level data; replace with de‑identified summaries or process metrics.
Build three portfolio pieces following the problem‑approach‑impact format and host them on a public GitHub repo with clear READMEs.
Work through a structured preparation system (the PM Interview Playbook covers data‑science product case interviews with real debrief examples) to sharpen your judgment‑first storytelling.
Practice a 90‑second verbal summary of each resume bullet, focusing on the decision you enabled rather than the tools you used.
Review Lilly’s recent press releases and pipeline updates to mirror their language in your summary and cover letter.

Mistakes to Avoid

BAD: “Experienced in Python, R, SQL, machine learning, and data visualization.”

GOOD: “Built a propensity‑score matching model in R that reduced bias in retrospective chemotherapy effectiveness estimates, supporting a $5 M market‑access submission.”

The first line is a generic skills list that gives no judgment signal; the second line shows a decision (choosing propensity scoring) and a business outcome.

BAD: Including a screenshot of a raw patient‑level dataset with visible IDs.

GOOD: Showing a aggregated Kaplan‑Meier curve with confidence intervals and a note: “Based on 8 k de‑identified patients from a Lilly‑sponsored study; IDs removed per DUA.”

The first mistake reveals poor confidentiality judgment; the second demonstrates awareness of data‑use constraints while preserving insight.

BAD: Listing “deep learning expert” without explaining why a simpler model was chosen.

GOOD: “Experimented with a 3‑layer neural network for readmission prediction (AUC 0.78) but selected a logistic regression with L1 penalty after clinical stakeholders requested interpretable odds ratios for formulary decisions.”

The first signals a focus on technique over impact; the second signals judgment about model trade‑offs and stakeholder needs.

FAQ

What length should my Eli Lilly data scientist resume be?

A one‑page resume is sufficient for candidates with less than eight years of experience; hiring managers in Lilly’s Analytics org told me they spend an average of 45 seconds on the first pass, so every line must convey a judgment‑enabled impact. If you have more than eight years, a two‑page resume is acceptable only if the second page contains leadership or cross‑functional initiative details that cannot be compressed without losing nuance.

How many portfolio pieces should I include, and what format works best?

Three pieces are the sweet spot; any fewer feels thin, and any more dilutes focus. Each piece should be a two‑page PDF (or a GitHub repo with a README) that follows the problem‑approach‑impact structure, includes a synthetic‑data reproducible notebook, and ends with a one‑sentence “decision enabled” statement. In a 2025 debrief, a candidate who submitted five pieces was asked to combine two because the reviewers could not discern which impact was most relevant to the role.

What salary range can I expect for a data scientist role at Eli Lilly in 2026?

Based on recent offer bands shared by candidates who closed offers in late 2025, the base salary for a level‑III data scientist (individual contributor) ranges from $115 k to $135 k, with an annual target bonus of 10‑15 % and equity grants that vest over four years.

Total compensation typically falls between $130 k and $155 k for candidates with three to five years of relevant experience and a strong portfolio of judgment‑driven projects. Negotiations often hinge on the demonstrated ability to move a specific Lilly metric, such as trial‑cycle‑time reduction or market‑access model accuracy.

Ready to build a real interview prep system?

Get the full PM Interview Prep System →

The book is also available on Amazon Kindle.